Colin Sandercock
SVP, GENERAL COUNSEL · Cue Biopharma, Inc.
Individual
- 2025
- Apr 10, 2026
- 2
Filings (90d)
Other insiders active in the same stocks
Insiders who reported open-market trades in the last 12 months at the companies Colin Sandercock files at. Multiple unrelated insiders buying the same stock within a short window, cluster buying, has historically been one of the strongest Form 4 signals.
- Shao-Lee Lin - $2.91M in CUE purchases and sales in the last 12 months
- Sumita Ray - $317K in CUE purchases and sales in the last 12 months
- Michael Vincent Meluzio - $201K in CUE purchases and sales in the last 12 months
- Pasha Sarraf - $100K in CUE purchases and sales in the last 12 months
More insiders (A-Z)
Browse nearby insider profiles in alphabetical order.
Frequently asked questions
Who is Colin Sandercock?
Colin Sandercock is a corporate insider, tracked as SVP, GENERAL COUNSEL of Cue Biopharma, Inc. (CUE). InsiderAlpha holds 2 primary Form 4 filings for them, the earliest from 2025, updated as new SEC EDGAR filings are processed.
When did Colin Sandercock last file a Form 4?
The most recent primary Form 4 on record is dated 10 April 2026, one of 2 filings going back to 2025.